All In MedTech

Device Trial Radar · NCT03962517

Effect of GEMS-H on Locomotor Function in Adults

Last checked: Nov 20, 2026Latest source record: Apr 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

70

Actual

Start

May 28, 2019

Primary completion

Feb 5, 2020

Study completion Feb 5, 2020

Sponsor

Lead sponsor
Samsung ElectronicsNot on our public-company list
Sponsor type
Industry
First posted
May 24, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 19 years, up to 84 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate the effect of training with the Gait Enhancing and Motivating System-Hip (GEMS-H) vs. training without the GEMS-H on locomotor function in adults. The investigator hypothesizes that long-term GEMS-H use would improve locomotor function. Specifically, individuals in the GEMS-H group will show faster gait speed compared to those in the control group.

Conditions

  • Adults
  • Middle Age
  • Aged
  • Aged, 80 and Over

Interventions

  • with Gait Enhancing and Motivating System-Hip (GEMS-H)Device

    The intensity of training: between 12 and 16 in borg's rating of perceived exertion scale. Assessments consist of gait function, cardiopulmonary metabolic energy cost, physical performance, balance, physical level, pain, fall efficacy, depression, quality of life and activities of daily living.

  • without Gait Enhancing and Motivating System-Hip (GEMS-H)Other

    The intensity of training: between 12 and 16 in borg's rating of perceived exertion scale.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in 10 Meter Walk Test-Self Selected Velocity (sec) from Baseline to Post-Training AssessmentTime frame: Baseline Assessment, Post Training Assessment (6 weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Samsung Medical Center

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.